Yesterday, the market showed an early decline, and rebounded in the afternoon with a width fluctuation of nearly V-shaped fluctuation. Although the three major stock indexes remained falling in the final session, the daily K-lines all closed with a long lower shadow.

Yesterday, , the market showed an early decline, and rebounded in the afternoon, which was close to the width of V-type . Although the three major stock indexes were still falling in the final session, the -day K-line all closed K-line with a long lower shadow line.

Yesterday's morning comment said, "Yesterday's afternoon comment is expected to maintain a weak fluctuation trend in the afternoon, and the time-sharing adjustment will continue until tomorrow. Therefore, there is a high probability that the market will still have a need for adjustment today, but judging from the nature of the adjustment, it is still a time-sharing adjustment for the time being." Judging from the actual performance of the market yesterday, although there was a certain adjustment during the session, the Shanghai and Shenzhen main boards still stubbornly closed on the 5-day moving average in the final session. Obviously, this wave of adjustments meets the expectations of time-sharing level adjustment.

in the morning comment yesterday, also talked about

. So since the index is still above the 5-day moving average, then continue to follow the trend. Of course, there are signs of weakness in terms of the current volume and trend of the market, but since the trend has not changed, it means that there is still an opportunity for operation. Even if we want to do a stage, we need to build a top pattern, and we may continue to fluctuate like this for a day or two. Then, according to our recent thinking, we can completely ignore the market and continue to focus on stock .

Judging from the performance of the sector yesterday, the pharmaceutical sector collectively rose sharply in the early trading, and the data security and information innovation sectors rose again in the afternoon. It is obvious that pharmaceutical and information innovation are still the absolute main lines at present.

Recently, it has been suggested that everyone focus on the pharmaceutical and medical sector. The mid-term logic is too strong. As long as there is adjustment, it is an opportunity. Look at the adjustment of pharmaceutical stocks on Wednesday. Is it another opportunity? Yesterday, the State Council’s joint prevention and control press conference released a number of optimization measures, which emphasized that, first, continue to strengthen the construction of designated hospitals; second, strengthen the construction of square cabin hospitals ; third, continue to strengthen the construction of fever clinics . Obviously, these policies are obviously beneficial to the medical device sector, and today’s hot topics may be tilted from medicine to medical devices.